(Q34587583)

3 August 2017

1 reference

title

Commercial molecular diagnostics in the U.S.: The Human Genome Project to the clinical laboratory (English)

1 reference

3 August 2017

Jean Amos

1

1 reference

3 August 2017

Meeta Patnaik

series ordinal

2

1 reference

3 August 2017

publication date

1 April 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

19

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

324-333

1 reference

Mutation detection 2001: Sixth International Symposium on Mutations in the Human Genome, May 3-7, 2001, Bled, Slovenia.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10061

DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10061

Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10061

Laboratory standards and guidelines for population-based cystic fibrosis carrier screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10061

American College of Medical Genetics consensus statement on factor V Leiden mutation testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10061

Improved detection of cystic fibrosis mutations in the heterogeneous U.S. population using an expanded, pan-ethnic mutation panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10061

Initial sequencing and analysis of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10061

Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10061

Identification of the cystic fibrosis gene: genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10061

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10061

Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10061

Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10061

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10061

Identification of the cystic fibrosis gene: chromosome walking and jumping

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10061

Statement on Use of Apolipoprotein E Testing for Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10061

Fragile X syndrome: diagnostic and carrier testing. Working Group of the Genetic Screening Subcommittee of the Clinical Practice Committee. American College of Medical Genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10061

A Novel Mutation in the Cystic Fibrosis Gene in Patients with Pulmonary Disease but Normal Sweat Chloride Concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10061

Genetic testing. Families sue hospital, scientist for control of Canavan gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10061

21 January 2018

Identifiers

DOI

10.1002/HUMU.10061

1 reference

release_7ijq6wo2ing67hqkp473vmcykm

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7ijq6wo2ing67hqkp473vmcykm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference